Patent ID: 11866457
Assignee: SAVID THERAPEUTICS INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 4:
5. A kit, comprising:
(i) a compound of formula (3) or a salt thereof:, wherein L10 and L12 each independently represent an alkylene group containing 1 to 10 carbon atoms, —CONH—, —NHCO—, —O—, or a combination thereof; L11 represents a trivalent linking group; L13 represents an alkylene group containing 1 to 10 carbon atoms, —CONH—, —NHCO—, —O—, or a combination thereof, and L13 also comprises a group represented by formula:, L14 represents an alkylene group containing 1 to 10 carbon atoms, —CONH—, —NHCO—, —O—, or a combination thereof; and Sugar represents a sugar residue, and

(ii) a fusion of a streptavidin mutant and a molecular probe,
wherein the streptavidin mutant consists of the amino acid sequence as set forth in SEQ ID NO: 3, in which the amino acid residue at position 37, Asn, is substituted with another amino acid residue, and
wherein the molecular probe is an antibody, peptide, nucleic acid, or aptamer.